Skip to main content
Albert David Ltd. logo

Albert David Ltd. — Investor Relations & Filings

Ticker · ALBERTDAVD ISIN · INE155C01010 LEI · 3358007IQAE63N68CT31 BSE.NS Manufacturing
Open in API
Filings indexed 584 across all filing types
Latest filing 2026-05-30 Board/Management Inform…
Country IN India
Listing BSE.NS ALBERTDAVD

About Albert David Ltd.

https://www.albertdavidindia.com

Albert David Ltd. specializes in the manufacturing and marketing of pharmaceutical formulations, infusions, and herbal preparations. The company’s product portfolio encompasses a wide range of therapeutic segments, including anti-infectives, gastrointestinal agents, and ophthalmic solutions. A significant area of expertise lies in the production of large and small volume parenterals and specialized placenta extract-based treatments used for tissue regeneration and wound healing. The organization maintains advanced production facilities and focuses on research and development to support its diverse clinical offerings. Its operations serve a broad spectrum of healthcare needs across various global markets, emphasizing quality control and technical precision in its manufacturing processes.

Recent filings

Filing Released Lang Actions
Resignation
Board/Management Information Classification · 87% confidence The document is an official intimation under SEBI LODR Regulations regarding the resignation of a senior managerial personnel (Head-Operations) and includes annexures with details of the change. This fits the definition of “Board/Management Information” (announcement of changes in senior management).
2026-05-30 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-30 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-30 English
Resignation of Senior Managerial Personnel
Board/Management Information Classification · 95% confidence The document is a formal disclosure under Regulation 30 of SEBI LODR Regulations informing the stock exchanges of the resignation of a senior managerial personnel (Head-Operations). It includes Annexure-A with details of the change and a resignation email as Annexure-B. This is clearly an announcement of a change in senior management. Therefore, it falls under Board/Management Information (MANG).
2026-05-30 English
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
Regulatory Filings Classification · 92% confidence The document is a Secretarial Compliance Report submitted under SEBI (LODR) Regulation 24A(2), prepared by the Company Secretary and filed with stock exchanges. It is not an annual or interim financial report, nor a proxy or AGM material, nor an audit of financial statements. Rather, it is a statutory compliance filing/certificate under listing regulations. This falls under the ‘Regulatory Filings’ category (RNS).
2026-05-27 English
Updates
Board/Management Information Classification · 80% confidence The document is the “Outcome of the Board Meeting” filed under SEBI Listing Regulations 30 & 33 to stock exchanges. It lists board decisions including the appointment of a new CEO, re-appointment of auditors, audited financial results (attached as Annexure B), dividend recommendation, AGM date and record date. While it includes audited results, the report itself is published as an annexure and the document’s primary purpose is to announce board decisions and management changes. It is not a standalone annual or interim report, nor merely a short RPA. It most closely matches a Board/Management Information disclosure (MANG).
2026-05-14 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.